Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | RAC2 | P15153 | 1/20 | 0.30 |
| ▸ | RAC3 | P60763 | 1/20 | 0.30 |
| ▸ | CDC42 | P60953 | 1/20 | 0.30 |
| ▸ | RAC1 | P63000 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17108976 | 0.93 | KDM4E (0.39) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL16484686 | 0.93 | KDM4E (0.42) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL15335605 | 0.91 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL16484462 | 0.89 | NPC1 (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL17108975 | 0.88 | L3MBTL1 (0.51) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL21116708 | 0.88 | L3MBTL1 (0.51) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL17108977 | 0.86 | KDM4E (0.35) | KDM4EATML3MBTL1FEN1 | |
| SCHEMBL16484493 | 0.86 | L3MBTL1 (0.49) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL17108990 | 0.85 | NPC1 (0.36) | KDM4E | |
| SCHEMBL16484650 | 0.85 | MAPT (0.36) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | YBX1, ATXN2L, ATXN2 | KDM4E 2405/4885ATM 3393/4885L3MBTL1 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.